AI assistant
Celularity Inc — Director's Dealing 2022
Aug 31, 2022
34506_dirs_2022-08-30_54a18531-c83a-4def-af30-38c828bb0215.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2022-08-26
Reporting Person: SCULLEY JOHN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-26 | Class A Common Stock | M | 768594 | $0.28 | Acquired | 804739 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-26 | Stock Option (Right to Buy) | $0.28 | M | 768594 | Disposed | 2027-06-02 | Class A Common Stock (768594) | Direct |
Footnotes
F1: These shares include 36,145 restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of (i) July 13, 2023, such date being the one-year anniversary of the date of grant, and (ii) the next annual stockholder meeting; in each case subject to the Reporting Person's continuous service with the Issuer through such date
F2: This option is fully vested and exercisable.